Breast Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. population: women, 18-50 years old, before menopause; 2. Patients who underwent breast cancer radical surgery 5 years ago; 3. Histopathology of ER positive and / or PR positive; 4. Taking TAM and /or toremifene for adjuvant endocrine therapy after surgery; 5. Informed consent has been signed; 6. Patients with poor general condition, ECOG 3 or 4, can't be completed survey questionnaire independently, could authorize a legal principal to sign the informed consent and complete survey questionnaire truthfully.
Exclusion criteria
Exclusion criteria: 1. Consistent with the definition of menopause; 2. TAM or toremifene drug have been used, but the period less than 1 months; 3. Initial treatment for endocrine therapy using AI/TAM combined with LHRHa; 4. Patients with distant metastasis, such as bone, brain, lung metastasis, or residual tumor lesions have been found in 3 months after the operation from auxiliary examination ; 5. Other malignant tumors (not including basal cell carcinoma or endometrial cancer have been cured).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence;Disease-free survival;Recurrence free survival;5 years survival rate; | — |
Countries
China